Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Clinical trial NCT06349642 · RECRUITING

Trial details

NCT number: NCT06349642
Sponsor: Mayo Clinic
Status: RECRUITING
Study type: OBSERVATIONAL

Early Stage Triple-Negative Breast Carcinoma Metastatic Bladder Urothelial Carcinoma Metastatic Cervical Carcinoma Metastatic Clear Cell Renal Cell Carcinoma Metastatic Colorectal Carcinoma Metastatic Endometrial Carcinoma Metastatic Esophageal Carcinoma Metastatic Liver Carcinoma Metastatic Lung Non-Small Cell Carcinoma Metastatic Malignant Skin Neoplasm Metastatic Malignant Solid Neoplasm Resectable Lung Non-Small Cell Carcinoma

Start date: 2024-04-24
Primary completion: 2027-05-01
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.